FDA.reportPublic FDA data

belantamab mafodotin-blmf 70 MG Injection [Blenrep]

RxCUI
2725587
RxNorm name
belantamab mafodotin-blmf 70 MG Injection [Blenrep]
Display name
belantamab mafodotin-blmf 70 MG Injection [Blenrep]
Full name
belantamab mafodotin-blmf 70 MG Injection [Blenrep]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:16

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761440Blenrepbelantamab mafodotin-blmf351(a)Rx2026-06-01

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
aef7c34c-fef8-407c-99c0-a68aded53c60belantamab mafodotin-blmf 70 MG Injection [Blenrep]SBD1These highlights do not include all the information needed to use BLENREP safely and effectively. See full prescribing information for BLENREP. BLENREP (belantamab mafodotin-blmf) for injection, for intravenous use Initial U.S. Approval: 202020251023
aef7c34c-fef8-407c-99c0-a68aded53c60BLENREP 70 MG InjectionPSN1These highlights do not include all the information needed to use BLENREP safely and effectively. See full prescribing information for BLENREP. BLENREP (belantamab mafodotin-blmf) for injection, for intravenous use Initial U.S. Approval: 202020251023
aef7c34c-fef8-407c-99c0-a68aded53c60Blenrep 70 MG InjectionSY1These highlights do not include all the information needed to use BLENREP safely and effectively. See full prescribing information for BLENREP. BLENREP (belantamab mafodotin-blmf) for injection, for intravenous use Initial U.S. Approval: 202020251023